Aurinia Pharmaceuticals Inc (AUPH)

[Merc1]

Realistically thinking, to my ARIAD brethren, I am not expecting a crazy run up, maybe to 25, then it will settle back down somewhat lower. Isn't this what happened with Ariad, got approval ran up to 25 or so, from 17, then the October debacle (this is IIRC).

Also, what's the chance they will do another offering given their track record? Not sure what to do, most likely just going to sit back and ride things out until thy start generating revenue and ideally a buyout, which is always nice because the decision is basically made for you, ha.